Healthcare provider profile · identity verified

Alisa B Cahill, MD

Family Practice · OVERLAND PARK, KS · NPI 1609829233

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	471	132
Atorvastatin Calcium	Atorvastatin Calcium	447	125
Levothyroxine Sodium	Levothyroxine Sodium	442	100
Metformin Hcl Er	Metformin Hcl	414	112
Losartan Potassium	Losartan Potassium	333	83
Pantoprazole Sodium	Pantoprazole Sodium	307	96
Gabapentin	Gabapentin	299	83
Amlodipine Besylate	Amlodipine Besylate	288	76
Lisinopril	Lisinopril	273	74
Omeprazole	Omeprazole	233	59
Alendronate Sodium	Alendronate Sodium	222	70
Duloxetine Hcl	Duloxetine Hcl	198	45
Metoprolol Succinate	Metoprolol Succinate	192	50
Hydrochlorothiazide	Hydrochlorothiazide	169	49
Sertraline Hcl	Sertraline Hcl	166	47
Simvastatin	Simvastatin	162	46
Jardiance	Empagliflozin	128	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	125	27
Meloxicam	Meloxicam	125	38
Tramadol Hcl	Tramadol Hcl	117	28
Ozempic	Semaglutide	112	22
Clonazepam	Clonazepam	108	22
Escitalopram Oxalate	Escitalopram Oxalate	107	27
Potassium Chloride	Potassium Chloride	100	29
Tamsulosin Hcl	Tamsulosin Hcl	99	27
Pravastatin Sodium	Pravastatin Sodium	97	27
Estradiol	Estradiol	92	35
Fluoxetine Hcl	Fluoxetine Hcl	88	22
Montelukast Sodium	Montelukast Sodium	87	26
Bupropion Xl	Bupropion Hcl	85	24
Metformin Hcl	Metformin Hcl	85	22
Quetiapine Fumarate	Quetiapine Fumarate	84	24
Fluticasone Propionate	Fluticasone Propionate	81	24
Ezetimibe	Ezetimibe	80	21
Zolpidem Tartrate	Zolpidem Tartrate	77	19
Alprazolam	Alprazolam	76	20
Famotidine	Famotidine	73	23
Januvia	Sitagliptin Phosphate	71	18
Carvedilol	Carvedilol	68	24
Celecoxib	Celecoxib	68	26
Trazodone Hcl	Trazodone Hcl	66	23
Albuterol Sulfate Hfa	Albuterol Sulfate	64	25
Lovastatin	Lovastatin	64	11
Metoprolol Tartrate	Metoprolol Tartrate	62	16
Furosemide	Furosemide	61	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	20
Mounjaro	Tirzepatide	58	11
Farxiga	Dapagliflozin Propanediol	53	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	53	33
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	17
Eliquis	Apixaban	52	13
Citalopram Hbr	Citalopram Hydrobromide	51	13
Doxycycline Hyclate	Doxycycline Hyclate	51	22
Trulicity	Dulaglutide	50	12
Hydroxyzine Hcl	Hydroxyzine Hcl	49	19
Spironolactone	Spironolactone	49	14
Fenofibrate	Fenofibrate Nanocrystallized	46	suppressed
Glimepiride	Glimepiride	46	14
Temazepam	Temazepam	46	suppressed
Atenolol	Atenolol	44	12
Prednisone	Prednisone	44	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Synthroid	Levothyroxine Sodium	41	12
Bupropion Hcl Sr	Bupropion Hcl	40	12
Venlafaxine Hcl Er	Venlafaxine Hcl	40	11
Allopurinol	Allopurinol	39	11
Sucralfate	Sucralfate	39	suppressed
Aripiprazole	Aripiprazole	38	11
Donepezil Hcl	Donepezil Hcl	38	12
Hydralazine Hcl	Hydralazine Hcl	38	12
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Topiramate	Topiramate	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	11
Dicyclomine Hcl	Dicyclomine Hcl	35	11
Pregabalin	Pregabalin	35	13
Ibandronate Sodium	Ibandronate Sodium	34	14
Linzess	Linaclotide	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	12
Chlorthalidone	Chlorthalidone	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Rizatriptan	Rizatriptan Benzoate	31	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	29	suppressed
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Ramipril	Ramipril	28	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	14
Azelastine Hcl	Azelastine Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Clobetasol Propionate	Clobetasol Propionate	23	15
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Risperidone	Risperidone	22	suppressed
Naltrexone Hcl	Naltrexone Hcl	21	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Diazepam	Diazepam	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Metronidazole	Metronidazole	18	14
Paxlovid	Nirmatrelvir/Ritonavir	18	17
Cephalexin	Cephalexin	17	15
Enalapril Maleate	Enalapril Maleate	17	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	17	suppressed
Nystatin	Nystatin	17	11
Colestipol Hcl	Colestipol Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Cefdinir	Cefdinir	15	13
Clonidine Hcl	Clonidine Hcl	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Febuxostat	Febuxostat	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	14	suppressed
Niacin Er	Niacin	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Tarina Fe 1-20 Eq	Norethindrone-E.Estradiol-Iron	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Indapamide	Indapamide	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Baclofen	Baclofen	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Finasteride	Finasteride	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Tramadol Hcl Er	Tramadol Hcl	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error